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Summary 
 
A trial was conducted using 723 crossbred 
heifers (468 lb initially) to evaluate the effects 
of including melengestrol acetate (MGA) in 
receiving diets on growth performance, mor-
bidity, mortality, and carcass characteristics.  
Treatments were: 1) MGA included in the re-
ceiving diet at a rate of 0.5 mg per heifer daily 
or 2) no MGA in the receiving diet. Diets 
were fed once daily and contained 42% steam-
flaked corn, 45% alfalfa hay, 6% steep liquor, 
and 2% tallow; monensin and tylosin were 
included.  Receiving diets were fed for 35 
days.  After 35 days MGA was fed to all heif-
ers, and cattle were stepped up to common 
finishing diets.  Cattle exhibiting clinical signs 
of bovine respiratory disease (BRD) were 
treated with Excenel (1 ml/100 lb body 
weight) for 3 days.  Animals requiring follow-
up treatment received the same therapy.  Cat-
tle pulled a third time received oxytetracycline 
(4.5 ml/100 lb body weight) and Predef (5 
ml/heifer).  Initial respiratory pulls (73.9% for 
MGA and 77.3% for no MGA), re-treatments, 
and death loss were not different (P>0.40) 
during the first 35 days.  The number of heif-
ers requiring a third antibiotic treatment 
tended (P=0.09) to be higher for heifers not 
receiving MGA.  Average daily gain (deads 
out) for the first 35 days tended to be higher 
for heifers fed MGA (P=0.06), but dry matter 
intake and feed efficiency were not different 
between treatments (P>0.17).  Gain through-
out the 220-day feeding period was 2.6% 
higher for cattle fed MGA during the receiv-
ing phase (P=0.05).  Overall, feed intake and 
feed efficiency were not different (P>0.50) 
between treatments, but heifers fed MGA dur-
ing the initial receiving period tended to have 
heavier carcass weights (P=0.13).  No differ-
ences were detected in quality grade, yield 
grade, or marbling (P>0.23).  Feeding MGA 
during the initial 35 days after arrival may im-
prove gain and carcass weights. 
 
Introduction 
 
Bovine respiratory disease (BRD) has 
enormous economic impact on the cattle in-
dustry as a result of its effects on labor cost, 
antibiotic treatment, feed efficiency, and car-
cass value.  BRD is seldom the result of a sin-
gle factor, but rather a result of a variety of 
environmental stresses that facilitate invasion 
of the lungs by opportunistic pathogenic bac-
teria such as the gram-negative Pasteurella 
multocida and Pasteurella haemolytica.  
Gram-negative bacterial infections are charac-
terized by the animal's reaction to components 
of the bacterial cell wall, frequently resulting 
in elevated body temperatures and production 
of pro-inflammatory cytokines.  Cytokines are 
protein mediators produced by immune cells 
in response to a foreign antigen.  Cytokines 
play an important role in immune function, 
but excess or prolonged production may be 
deleterious to epithelial tissue.  The pro-
inflammatory cytokines, which include tumor 
necrosis factor-alpha, have been implicated as 
having inhibitory effects on feed consumption, 
glucose regulation, and glycogen synthesis. 
Suppressing the release of pro-inflammatory 
cytokines may be beneficial to the well-being 
and future productivity of disease challenged 
animals.
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Studies conducted with other animal spe-
cies have successfully suppressed production 
of tumor necrosis factor-alpha through ad-
ministration of exogenous progesterone com-
pounds, thus increasing appetite and weight 
gain. We hypothesized that melengestrol ace-
tate (MGA), a synthetic progesterone com-
monly used to suppress estrus in feedlot heif-
ers, may have application in receiving cattle to 
improve growth performance and health. Our 
objective was to determine the effects of add-
ing MGA to receiving diets fed to pre-pubertal 
heifer calves on morbidity, mortality, and 
growth performance throughout the feeding 
period, as well as carcass characteristics.  This 
paper summarizes our observations during the 
initial 35 days following arrival and overall 
performance at the feedlot. 
 
Experimental Procedures 
 
Seven hundred twenty-three crossbred 
heifers were transported from Missouri and 
Kentucky sale barns to the KSU Beef Cattle 
Research Center in Manhattan, KS.  They 
were placed into pens upon arrival, given free 
access to water and hay, and processed within 
24 hours after arrival.  Average weight at ini-
tial processing was 468 ± 5 lb.  Cattle were 
identified with uniquely numbered ear tags, 
individually weighed, and given injections of 
4-way viral (Bovishield 4) and 7-way clos-
tridial (Fortress-7) vaccines.  Implanting was 
delayed to avoid hormone interactions with 
MGA. Cattle were allotted to 12 pens of 46 to 
53 head each, and 10 pens of 13 to 14 head 
each.  Pens of heifers were randomly assigned 
to two treatments: 1) no MGA, or 2) 0.5 mg 
MGA per heifer daily included in the diet for 
the first 35 days.  A second dose of Fortress-7 
was given 7 to 10 days after initial processing. 
 
Initial diets contained 60% concentrate, 
utilizing steam-flaked corn as the primary en-
ergy source (Table 1).  The amount of feed 
offered was determined by a 7:00 a.m. feed 
call so that only traces of feed remained each 
day.  The entire daily ration for each pen was 
delivered by approximately 8:00 a.m. each 
day.  Excess residual feed was removed from 
the bunk to prevent spoilage and was weighed 
and accounted for in calculating feed intake.  
On day 21, heifers were transitioned to a 97% 
concentrate finishing ration containing a mix-
ture of steam-flaked corn and wet corn gluten 
feed using a series of five steps. 
 
On day 35, MGA was added to all diets, 
and cattle were individually weighed and im-
planted with Ralgro.  On approximately day 
95 cattle were individually weighed, re-
implanted with Revalor-H, and then were real-
located equally across treatments to a finish-
ing trial in which diets contained 4.0% tallow 
or 10% corn germ.  Thirteen chronic animals 
were removed from the study at this point.  
Cattle were slaughtered in two groups. On ap-
proximately day 195, 25% of the cattle from 
each treatment were shipped for slaughter. 
The remaining cattle were shipped at ap-
proximately day 223.  Cattle were slaughtered 
at a commercial abattoir in Emporia, KS, and 
carcass data were obtained following a 24-
hour chill. 
 
Cattle that exhibited clinical signs of respi-
ratory disease, including depression, lethargy, 
anorexia, coughing, rapid breathing, and nasal 
and(or) ocular discharge were treated with a 
subcutaneous injection of Excenel at the rate 
of 1 ml/100 lb body weight for 3 days. Cattle 
were placed into sick pens and then returned 
to their original pen following treatment. Cat-
tle pulled for a relapse were treated in the 
same manner.  Cattle requiring a third treat-
ment were given oxytetracycline at 6 ml/100 
lb body weight and PreDef 2x at 5 ml/heifer 
one time and returned to their pen. 
 
Results and Discussion 
 
Table 2 summarizes the performance, 
mortality, and morbidity of heifers during the 
35-day receiving trial.  MGA tended to in-
crease daily gains (P=0.06), which accounts 
for the differences in body weight at day 35 
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(540.5 and 525.8 lbs respectively, P=0.07) 
calculated on a deads-out basis (only animals 
sent to slaughter).  Incidence of respiratory 
disease treatments was not affected by MGA 
(P=0.41). Likewise, the number of heifers re-
quiring a second antibiotic treatment was not 
affected (P=0.44), but feeding MGA did tend 
(P=0.09) to reduce the number of heifers re-
quiring three treatments for BRD.  Death loss 
was not different between treatments 
(P=0.98).  Cattle continued to experience mor-
tality after day 35 with a 15.8 and 17.7% mor-
tality rate for cattle fed MGA and no MGA, 
respectively (P=0.62) for the entire feeding 
period (Table 3). 
 
Performance throughout the entire feeding 
period (receiving plus finishing on a deads-out 
basis) and carcass characteristics are shown in 
Table 3.  Daily gain throughout the entire re-
ceiving and finishing period tended to be in-
creased by feeding MGA in the receiving pe-
riod (P=0.05) thus increasing hot carcass 
weight (679 and 667 lbs, P=0.13).  However, 
feed intake and feed efficiency were not af-
fected by feeding MGA during the receiving 
phase.  The percentage of carcasses grading 
USDA Choice and Prime and USDA yield 
grades were not different between treatments 
(P>0.50). 
 
Heifers in this study experienced a high 
incidence of respiratory challenge and mortal-
ity, thus leading to relatively poor perform-
ance for both treatments during the receiving 
period.  Including MGA in diets of heifers 
immediately after arrival in the feedlot may be 
an effective means of reducing chronicity, as 
indicated by reductions in the number of heif-
ers pulled for BRD three times, and of im-
proving subsequent finishing performance.  
Further studies utilizing MGA in diets of 
lightweight receiving heifers are necessary to 
determine if results can be repeated with more 
moderate disease challenges. 
 
 
Table 1.  Experimental Diets (% of Dry Matter) Fed During the 35-Day Receiving Period 
 Treatment 
Ingredient MGA No MGA 
Steam-flaked corn 42.0 42.0 
Alfalfa hay 45.4 45.4 
Steep liquor 6.1 6.1 
Tallow 2.0 2.0 
Soybean meal 3.6 3.6 
Vitamin/mineral premix1 0.4 0.4 
R-T-MGA premix2 2.5 - 
R-T premix3 - 2.5 
Crude protein, analyzed 17.0 17.0 
1Formulated to provide 1500 IU/lb vitamin A, 20 IU/lb vitamin E, 0.1 ppm Co, 0.6 ppm I, 60 
ppm Mn, 0.25 ppm Se, 60 ppm Zn, and 10 ppm Cu. 
2
Rumensin/Tylan/MGA premix was fed in a ground corn carrier and provided 300 mg monensin, 
90 mg tylosin, and 0.5 mg MGA per heifer daily. 
3
Rumensin/Tylan premix was fed in a ground corn carrier and provided 300 mg monensin and 90 
mg tylosin per heifer daily. 
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Table 2.  Health and Performance During the 35-Day Receiving Period for Heifers Fed No 
MGA  or 0.5 mg MGA per Heifer Daily 
 MGA in Receiving Diet   
Item 0.5 mg/day 0 SEM P-value 
1st Treatment, % 73.9 77.3 2.87 0.41 
2nd Treatment, % 40.6 44.4 3.45 0.44 
3rd Treatment, % 20.9 29.5 3.42 0.09 
Dead, % 9.8 9.9 2.41 0.98 
Performance1     
    Initial weight, lb 470.9 467.9 4.90 0.70 
    End weight, lb 540.5 525.8 6.29 0.07 
    Daily gain, lb 2.00 1.66 0.12 0.06 
    Feed intake, lb/day 8.76 8.13 0.32 0.17 
    Feed:gain 4.39 4.89 - 0.28 
1Deads out basis.  
 
 
Table 3. Performance Throughout the Receiving and Finishing Period and Carcass Traits 
for Heifers Fed No MGA or 0.5 mg MGA per Heifer Daily During the 35-Day Receiving 
Period 
 MGA in Receiving Diet   
Item    0.5 mg/day 0 SEM P-value 
Performance1     
    End weight, lb 1051.5 1033.2 7.86 0.12 
    Daily gain, lb 2.78 2.71 0.02 0.05 
    Feed intake, lb/day 14.16 13.97 0.24 0.59 
    Feed:gain 5.09 5.14 - 0.69 
    Dead, % 15.8 17.7 2.57 0.62 
Carcass trait     
    Carcass weight, lb 678.6 666.9 5.10 0.13 
    Dressing, % 64.7 64.3 0.20 0.09 
    Rib eye area, in2 11.91 11.67 0.17 0.31 
    12th rib fat thickness, in 0.55 0.54 0.01 0.82 
    Kidney, pelvic & heart fat, % 2.50 2.46 0.03 0.32 
    Marbling score Small41 Small38 7.0 0.81 
    Prime, % 4.1 3.2 1.1 0.55 
    Choice, % 67.7 69.3 2.5 0.66 
    Avg. Choice or greater, % 17.4 17.2 2.1 0.94 
    Select, % 27.2 26.1 2.7 0.79 
    Yield grade 1, % 2.5 4.2 0.9 0.23 
    Yield grade 2, % 26.8 21.5 3.1 0.25 
    Yield grade 3, % 53.7 56.5 2.2 0.38 
    Yield grade 4 & 5, % 17.1 17.9 1.8 0.76 
1Deads out basis. 
